Oncozyme Pharma Inc.

Oncozyme Pharma Inc. (Oncozyme) is engaged in developing novel cancer drugs. It has identified an anti cancer agent, pentamidine, targeting key DNA repair enzyme. Pentamidine is a drug used for the treatment of parasitic diseases such as Pneumocyctis carinii pneumonia. Oncozyme also conducts research in the areas of Endo-Exonuclease and Pentamidine as Inhibitor. Oncozyme through its clinical trails division conducted a study using pentamidine in patients with metastatic colon cancer trail, pancreatic cancer trial and breast and ovarian cancer undergoing standard second line and third line treatment. The company is headquartered in Montreal, Quebec, the Canada.

Street: 
555 Rene-Levesque Boulevard West
City: 
Montreal
Postcode: 
H2Z 1B1
Federal State : 
Canada
WebSite: 
www.oncozymepharma.com

Company Index Score

Current Index Score Historical Index Score
  • Oncozyme Pharma Inc. currently scores 50 % in the index.
  • Oncozyme Pharma Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Oncozyme Pharma Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets